Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.98 USD | -0.36% | +16.82% | +166.73% |
May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+166.73% | 731M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.39% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Transcript : Stoke Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 04